SEARCH:   Advanced

Blood, Vol. 113, Issue 4, 866-874, January 22, 2009 This Article Abstract Full Text Services Email this article to a friend Alert me to new issues of the journal Rights and Permissions Citing Articles Citing Articles via CrossRef Very late antigen-4 function of myeloblasts correlates with improved overall survival for patients with acute myeloid leukemia Blood Becker et al. 113: 866 Supplemental materials for: Becker et al Files in this Data Supplement: Table S1. Cytogenetic characteristics of N=175 included patients (PDF, 52.5 KB) Table S2. FLT3 ITD mutation status of N=175 included patients (PDF, 13.9 KB) Table S3. Proportional hazards regression analyses of OS by sVCAM-1 percent binding (PDF, 16.5 KB) Table S4. Treatment outcomes by inclusion status (PDF, 14.9 KB) Table S5. Comparison of 20 patients with fibronection-adherent cell data to 155 patients without those data (PDF, 52.9 KB) Table S6. Comparison of 24 patients with β1 activation data to 151 patients without those data (PDF, 53.9 KB) Figure S1. Flow cytometry gating on leukemic blasts (JPG, 28.9 KB) - (A) Gate on leukemic blast by forward scatter/side scatter. (B) Gate on CD45 positive cells (FITC) vs. side scatter. (C) 7AAD positive cell exclusion (gate on viable cells). (D) Example gate on positive population of cells expression α4 integrin. This Article Abstract Full Text Services Email this article to a friend Alert me to new issues of the journal Rights and Permissions Citing Articles Citing Articles via CrossRef

	Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020